Fri, 23 Jun 2017 13:46:18: Bluebird Bio rebuilds case for blood disorder gene therapy

Fri, 23 Jun 2017 12:45:58: Aveo soars as long-beleaguered cancer drug nears approval

Fri, 23 Jun 2017 09:12:53: Novartis-backed GenSight gets cash for gene therapy launch

Thu, 22 Jun 2017 13:14:34: EuroBiotech: More Articles of Note

Thu, 22 Jun 2017 12:59:20: Biotech bounces as the bones of Trump's plans on pricing emerge

Thu, 22 Jun 2017 12:19:15: Seven years after Merck deal, ElexoPharm offloads aldosterone synthase inhibitors to Angion

Thu, 22 Jun 2017 09:54:06: Eli Lilly completes expansion of San Diego biotech center

Thu, 22 Jun 2017 08:16:06: Celgene-backed cancer biotech Repare emerges from stealth with $68M

Wed, 21 Jun 2017 14:38:52: Clinigen makes 3 exclusive compassionate-use deals

Wed, 21 Jun 2017 13:16:28: Vineti scores $13M+, launches cloud-based platform for cell therapies

Wed, 21 Jun 2017 12:46:48: Sarepta signs another Duchenne gene therapy pact as it aims for wider treatment

Wed, 21 Jun 2017 11:34:31: Cash-strapped ImmunoCellular halts brain cancer vaccine trial, eyes 'strategic alternatives'

Wed, 21 Jun 2017 10:25:42: Gottliebís FDA to rethink targeted therapy regulation to speed development, drive down healthcare costs

Wed, 21 Jun 2017 08:19:40: Apple Tree helps Big Apple biotech Syntimmune in $50M series B

Tue, 20 Jun 2017 15:21:37: Flagship-backed Rubius raises $120M to take off-the-shelf red blood cell cancer therapeutics into the clinic

Tue, 20 Jun 2017 13:54:52: Merck Ventures, CRUK launch new immuno-oncology spinout biotech iOnctura

Tue, 20 Jun 2017 12:32:42: R&D costs growing, Roche shines and Novo high for ROI: Itís the EP report

Tue, 20 Jun 2017 12:10:55: Ionisí Akcea closes in on $125M IPO to fund phase 3 trials

Tue, 20 Jun 2017 11:46:43: Novartis' longer-acting AMD drug matches archrival Eylea in phase 3 trials

Tue, 20 Jun 2017 11:24:11: Parexel to go private in $5B Pamplona Capital buyout deal

Tue, 20 Jun 2017 10:01:48: Cell Medica buys clinical-phase WT1-TCR cell therapy

Mon, 19 Jun 2017 13:21:56: Novartis-backed Gamida Cell gains $40M for phase 3 work

Mon, 19 Jun 2017 12:48:14: Seattle Genetics stops all trials of '33A blood cancer drug after patient deaths

Mon, 19 Jun 2017 09:01:32: Woodford invests in Big Pharma-backed dementia fund

Mon, 19 Jun 2017 07:58:14: Parker-Tessa alliance tees up solid tumor I-O combinations